Board Attendee

Paul Sandland: Acting Chief Financial Officer

Committee Membership: Not applicable.

Skills and Experience: Paul qualified as a Chartered Certified Accountant in 2005. He spent five years post qualification at KPMG, during which time he was part of the team which advised the Group on its acquisition of VetXX in 2008.

Background: Paul was appointed as Acting Chief Financial Officer on 3 April 2019. Prior to this he was the Dechra Veterinary Products EU Finance Director. He was the Group Financial Controller of Dechra and Finance Director of Dechra Laboratory Services and Dechra Specialist Laboratories between January 2010 and April 2015.

External Appointments: None.


Senior Executive Team

The Senior Executive Team comprises the Executive Directors, the Acting Chief Financial Officer and the following:

Dr Susan Longhofer: Business Development and Regulatory Affairs Group Director

Background: Susan joined the Group in June 2005. A veterinarian with 30 years' experience in the industry, she leads a team of approximately 50 staff around the globe responsible for registering new products and maintaining the registrations of our existing products. She has assumed the Business Development role in 2015, searching out new products to continue to fill our product development pipeline.

Prior to joining Dechra, Susan worked for Virbac Corporation, Heska Corporation and Merck Research Laboratories. Susan holds an MS and a DVM in Veterinary Science and is a Diplomate, American College of Veterinary Internal Medicine. She is located in Kansas, USA.


Dr Anthony Lucas: Group Product Development Director

Background: Anthony joined Dechra in 2016 following the acquisition of Putney Inc. where he was Senior Vice President of R&D. Anthony is originally a veterinarian from Australia with five years in clinical practice including a residency in emergency and critical care. Following a Masters in veterinary pharmacology, PhD in human pharmacology and post-doc at the University of Kansas, he spent six years at Elanco in early drug development, technology acquisition and has a Six Sigma blackbelt.

In his six years at Putney, Anthony built the R&D team, which delivered ten FDA product approvals.

As the Group Product Development Director, Anthony leads a team of around 50 scientists across five global research centres, to efficiently deliver the pipeline of products to meet Dechra's growth needs. He is located in Maine, USA.


Mike Eldred: President North America

Background: Mike joined Dechra in 2004 and is responsible for Dechra Veterinary Products' North American business. Mike has more than 20 years' experience in the animal health sector, having held senior positions in business development, sales and operations at Virbac Corporation, Fort Dodge Animal Health and Sanofi Animal Health.

As our first employee in the USA, he has built the USA and Canadian team to 181 people and has grown sales revenue to £177.8 million. Mike has also been involved in several commercial agreements and acquisitions for the Group including Pharmaderm, DermaPet, Phycox Animal Health and Putney. Mike has a BA in Business, and an MBA. He is located in Kansas, USA.


Giles Coley: Dechra Veterinary Products International Group Director

Background: Giles joined Dechra in January 1999 as sales and marketing manager for Arnolds Veterinary Products having previously spent 14 years primarily involved in dairy farming business consultancy. During his time at Dechra he has been responsible for the launch and market development of our leading brand Vetoryl, as well as a number of our other key brands. Giles has also been an integral member of the teams that ensured fast and smooth integrations of several of our acquisitions, and in particular as lead in the integration of Apex in 2016 and Venco in 2019.

In his role of Dechra Veterinary Products International Group Director, his responsibilities are extremely varied and involve managing and growing our existing business through ANZ and Latin American business and distribution partners, as well as further developing our Dechra International strategy through product registrations and market development. Giles has a BSc degree in Agricultural Technology. He is located in Sansaw, UK.


Katy Clough: Group HR Director

Background: Katy joined Dechra in April 2014 from AppSense Ltd where she was the Vice President of HR Europe and Rest of the World. With over 15 years operating at Director level within Software, Health, Travel and Finance industries, Katy brings with her a wealth of HR expertise gained in both blue chip corporates and smaller entrepreneurial companies.

She has strong international, leadership and M&A experience and has taken responsibility for driving the global people agenda for the Dechra Group. She is located at Head Office, Northwich, UK.

Pets: None

Allen Mellor: Group IT Director

Background: Allen joined Dechra in April 2012 and has developed and implemented the Group IT strategy during this time. During the last 25 years, Allen has gained a breadth of experience from the implementation of diverse business solutions across multiple industry sectors including Justice, Education, Energy, Distribution and Retail. He has held several senior management positions encompassing software development, IT service provision and IT departmental management. His last role was as Head of IT for the BSS Group PLC, a leading plumbing and heating distribution company. Allen is currently responsible for all Group IT support to a multitude of internal customers. He is located at Head Office, Northwich, UK.


Simon Francis: Group Manufacturing and Supply Director

Background: Simon joined Dechra in 2019. He has over 20 years' experience in various senior roles within the Pharmaceutical industry. After completing a chemistry degree, Simon started his career with Bayer in Quality Control. He had a variety of UK pharmaceutical roles within quality, supply chain, production and operations, before moving to China as the site head for Boehringer Ingelheim. He then moved to their German headquarters, subsequently joining Sandoz (Novartis) as a Managing Director covering three German generic manufacturing sites. Latterly, Simon was the Head of Strategy Global Solids and a Novartis Senior Executive Team member based in Switzerland, responsible for product strategy, supply chain and product lifecycle across 35 manufacturing sites.

Simon is responsible for our manufacturing sites in Europe and the USA.

He is located at Head Office, Northwich, UK.


Melanie Hall: Company Secretary

Committee Membership: Disclosure

Background: Melanie joined Dechra in January 2010 as the Assistant Company Secretary, and was promoted to Deputy Company Secretary in May 2015 and Company Secretary in July 2017. Prior to joining Dechra she has gained over 25 years' experience in various company secretarial roles including at GKN plc, TRW Automotive Inc and Pendragon PLC. Melanie is a Fellow of the Institute of Chartered Secretaries and Administrators. She is located at Head Office, Northwich, UK.